KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Receivables (2016 - 2025)

Labcorp Holdings' Receivables history spans 17 years, with the latest figure at $2.3 billion for Q4 2025.

  • For Q4 2025, Receivables rose 14.52% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $2.3 billion, up 14.52%, while the annual FY2025 figure was $2.3 billion, 14.52% up from the prior year.
  • Receivables for Q4 2025 was $2.3 billion at Labcorp Holdings, roughly flat from $2.3 billion in the prior quarter.
  • Across five years, Receivables topped out at $3.1 billion in Q3 2021 and bottomed at $2.0 billion in Q4 2024.
  • The 5-year median for Receivables is $2.3 billion (2025), against an average of $2.5 billion.
  • The largest annual shift saw Receivables soared 48.09% in 2021 before it tumbled 32.94% in 2022.
  • A 5-year view of Receivables shows it stood at $3.0 billion in 2021, then crashed by 32.94% to $2.0 billion in 2022, then rose by 5.08% to $2.1 billion in 2023, then dropped by 5.94% to $2.0 billion in 2024, then increased by 14.52% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Receivables are $2.3 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025).